Atrial Overdrive Pacing Stability Classification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preventing and treating atrial fibrillation (AF) are limited, particularly when the intrinsic atrial rate exceeds a certain threshold, as conventional techniques may not effectively manage AF and can lead to repeated and painful cardioversion shocks.

Innovation Solution

The development of implantable medical devices that selectively perform atrial overdrive pacing within a specified range of intrinsic atrial rates, using measured intervals to classify activity as stable or unstable, and adjusting pacing rates based on past performance data recorded in a log.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cardioversion is used to treat atrial fibrillation, then the arrhythmia is terminated, but the patient experiences pain and the procedure may need to be repeated

Engineering Contradiction:
ImproveAF termination effectivenessVSAvoidpatient pain
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The device performs preliminary classification of atrial activity stability before delivering cardioversion therapy. By measuring intervals between intrinsic atrial depolarizations and classifying them as stable or unstable, the system determines whether cardioversion is likely to be effective, thereby avoiding unnecessary painful shocks when the activity is unstable and cardioversion is unlikely to succeed.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The device incorporates feedback mechanisms by recording past performance data in a log and using it to guide future therapy decisions. The system learns from previous cardioversion outcomes and adjusts its therapy selection based on this feedback, improving effectiveness while reducing unnecessary painful interventions.

Inventive Principle:
Principle #23Feedback

2Reliability

If atrial overdrive pacing is performed at high rates to prevent AF, then prevention effectiveness is improved, but device battery is depleted faster

Engineering Contradiction:
ImproveAF prevention effectivenessVSAvoidbattery consumption
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The device dynamically adjusts the atrial overdrive pacing rate based on the classified stability of intrinsic atrial activity. When activity is classified as stable, the system can use higher pacing rates for more effective prevention. When activity is unstable, the system reduces or suspends pacing to conserve battery energy, thereby optimizing the trade-off between prevention effectiveness and energy consumption.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes the pacing rate parameter based on the stability classification of atrial activity. By adjusting this key parameter dynamically, the device optimizes both the effectiveness of AF prevention and the conservation of battery energy, avoiding unnecessary high-rate pacing when it is unlikely to be effective.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If atrial overdrive pacing is performed when intrinsic atrial rate exceeds threshold, then therapy coverage is improved, but therapy effectiveness decreases

Engineering Contradiction:
Improvetherapy coverage rangeVSAvoidtherapy effectiveness
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The device performs preliminary classification of atrial activity stability before delivering overdrive pacing therapy. This preliminary assessment allows the system to identify when the intrinsic atrial activity is stable and therefore likely to respond to pacing therapy, even when rates exceed conventional thresholds. By gating therapy delivery on this stability classification, the system maintains effectiveness while expanding coverage to higher rates.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250135214A1Systems and methods for suppressing and treating atrial fibrillation and atrial tachycardia
Publication Date: 2025.05.01 PACESETTER INC
  • US20250135214A1 patent drawing
  • US20250135214A1 patent drawing
  • US20250135214A1 patent drawing

AI summary

Disclosed herein are implantable medical devices and systems, and methods for used therewith, that selectively perform atrial pacing at an atrial pacing rate that is faster than an intrinsic atrial rate of a patient while the patient is experiencing an atrial tachycardia or atrial fibrillation and the intrinsic atrial rate of the patient is within the specified range, to attempt to convert the arrhythmia to a normal sinus rhythm.